European Union -
English -
EMA (European Medicines Agency)
evrenzo
astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemic preparations - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
evrenzo 20mg tablets
astellas pharma ltd - roxadustat - tablet - 20mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
evrenzo 50mg tablets
astellas pharma ltd - roxadustat - tablet - 50mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
evrenzo 70mg tablets
astellas pharma ltd - roxadustat - tablet - 70mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
evrenzo 100mg tablets
astellas pharma ltd - roxadustat - tablet - 100mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
evrenzo 150mg tablets
astellas pharma ltd - roxadustat - tablet - 150mg
Bangladesh -
English -
DGDA (Directorate General of Drug Administration)
renesis 20 tablet
beacon pharmaceuticals plc - roxadustat - tablet - 20 mg
Bangladesh -
English -
DGDA (Directorate General of Drug Administration)
renesis 50 tablet
beacon pharmaceuticals plc - roxadustat - tablet - 50 mg
Bangladesh -
English -
DGDA (Directorate General of Drug Administration)
renesis 100 tablet
beacon pharmaceuticals plc - roxadustat - tablet - 100 mg
Bangladesh -
English -
DGDA (Directorate General of Drug Administration)
xadu 50 tablet
beximco pharmaceuticals ltd. - roxadustat - tablet - 50 mg